Latest News From Pharmachem

    December 2011

  • GXP – The Fundamentals for Working in a Regulatory Environment

    GXP – The Fundamentals for Working in a Regulatory Environment

    06 December, 2011

    The PharmaChem skillnet launched today their newly developed GXP course.The course was developed internally and candidates will be taken through an intensive 5 day course dealing with the fundamentals required to work in the pharmaceutical industry.

    Continue Reading »

  • Bayer, J&J's Xarelto wins key FDA nod, with warning

    Bayer, J&J's Xarelto wins key FDA nod, with warning

    07 December, 2011

    Bayer and Johnson & Johnson ($JNJ) snagged the crucial stroke-prevention indication for their new clot-fighter Xarelto. The FDA approval isn't without its caveats, however. FDA may have granted the new use despite objections from staffers, who had questioned the usefulness of a key study, but the agency didn't give Xarelto a snag-free label

    Continue Reading »

  • J&J to release new Doxil batches

    J&J to release new Doxil batches

    14 December, 2011

    Johnson & Johnson is releasing new batches of Doxil, a cancer drug that has been in short supply recently as a result of problems at contract manufacturer Ben Venue Laboratories, a unit of Boehringer Ingelheim.

    Continue Reading »